Basic Science Research: Trimodal therapy shows promise in oligometastatic PCaJuly 1st 2016
Other basic science research pearls include preliminary evidence from a porcine model suggesting botulinum toxin type A facilitates ureteral stone passage and the identification of two different microdeletions in the NELL1 gene on chromosome 11 in men with Peyronie's disease.
Stone Disease: New AUA guide discusses SWL vs. URSJune 24th 2016
Other key stone disease/endourology topics from the 2016 AUA annual meeting included the use of aspirin in percutaneous nephrolithotomy patients as well as the continuing debate over the benefit of medical expulsive therapy.
Shock wave lithotripsy: Down, but not outMarch 1st 2016
Once considered a primary option for kidney stone treatment, shock wave lithotripsy appears to be losing traction. Many urologists say its outcomes aren’t as reliable as those from ureteroscopy. But others say it remains an option that works well with proper patient selection and technique and offers what ureteroscopy doesn’t: a noninvasive option.
Smoking associated with greater risk of urolithiasisFebruary 1st 2016
Two-thirds of patients attending a urology clinic for the management of urolithiasis failed to meet physical activity guidelines. In addition, patients with recent symptomatic urolithiasis were significantly more likely to be current smokers than those without recent symptomatic urolithiasis, according to a recent study.
New Products: Single-use ureteroscope, new FDA Approvals for RCC treatment, and an App that helps IC, chronic prostatitis patientsJanuary 26th 2016
Check out the latest new products. From Single-use ureteroscope addresses shortcomings of reusable scopes, to an App that helps IC, chronic prostatitis patients choose the right foods and much more.
Uro Pipeline: 1st patients treated in phase III study of investigational BPH TxJanuary 1st 2016
Other pipeline products discussed in this article include an immunotherapy for metastatic bladder cancer, a treatment for lower urinary tract symptoms of BPH, and an investigational clear cell renal cell carcinoma treatment.
Non-adherence to stone meds raises hospitalization riskDecember 1st 2015
When it comes to urinary stone disease, it appears that prescribers know what they’re doing. According to a study presented at the World Congress of Endourology and SWL in London, non-adherence to kidney stone medications led to a significant increase in adverse health outcomes.
Single-use ureteroscope yields high-quality imagesDecember 1st 2015
Findings from preclinical studies evaluating the performance of an investigational single-use digital flexible ureteroscope (Lithovue, Boston Scientific) support it as a viable alternative to current non-disposable flexible digital and fiberoptic ureteroscopes, said Brian H. Eisner, MD, at the World Congress of Endourology and SWL in London.
Breaking new ground (and kidney stones) with ultrasoundNovember 1st 2015
Novel ultrasound-based techniques for propelling and breaking kidney stones could soon join ESWL and URS in the urologist’s treatment armamentarium. In this interview, Michael Bailey, PhD, discusses how these technologies work, what they’re capable of, and where they are in development.
Product Update: HIFU cleared, compact catheter launchedNovember 1st 2015
Other products highlighted in this slideshow include a trial system for incontinence therapy, a compact catheter, a wearable digital technology solution for continence care assessment and management, and laser fiber and sheath system.
New Products: App helps moviegoers with OAB, new mesh for sacrocolpopexy, and moreAugust 1st 2015
In this round-up of new urology products and services, learn about an app that helps moviegoers with OAB, a new mesh for sacrocolpopexy, and device/smartphone app that help women with pelvic floor exercises.
Alpha-blocker may have benefit in larger stonesJuly 27th 2015
While there is no benefit from using tamsulosin (Flomax) versus placebo for the treatment of small ureteral stones, there is a potential upside of increased passage from using the drug to treat 5- to 10-mm stones, according to a study from Australia published online in the Annals of Emergency Medicine (July 13, 2015).